Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy

Most patients who develop rectal cancer present with locoregionally advanced (T3 or node-positive) disease. The standard management of locoregionally advanced rectal cancer is neoadjuvant concurrent chemoradiotherapy (nCRT), followed by radical resection (low-anterior resection or abdominoperineal r...

Descripción completa

Detalles Bibliográficos
Autores principales: Solanki, Abhishek A, Chang, Daniel T, Liauw, Stanley L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747849/
https://www.ncbi.nlm.nih.gov/pubmed/23983475
http://dx.doi.org/10.2147/OTT.S34869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747849/
https://www.ncbi.nlm.nih.gov/pubmed/23983475
http://dx.doi.org/10.2147/OTT.S34869

Ejemplares similares